Surmodics, Inc.
SRDX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $548,853 | $450,255 | $423,046 | $765,334 |
| - Cash | $36,115 | $41,419 | $18,998 | $31,153 |
| + Debt | $33,242 | $33,251 | $14,806 | $13,706 |
| Enterprise Value | $545,980 | $442,087 | $418,854 | $747,887 |
| Revenue | $126,078 | $132,584 | $99,951 | $105,136 |
| % Growth | -4.9% | 32.6% | -4.9% | – |
| Gross Profit | $93,052 | $61,024 | $29,000 | $41,225 |
| % Margin | 73.8% | 46% | 29% | 39.2% |
| EBITDA | $4,728 | $15,150 | -$12,224 | $14,673 |
| % Margin | 3.8% | 11.4% | -12.2% | 14% |
| Net Income | -$11,542 | -$1,536 | -$27,274 | $4,237 |
| % Margin | -9.2% | -1.2% | -27.3% | 4% |
| EPS Diluted | -0.82 | -0.11 | -1.96 | 0.3 |
| % Growth | -645.5% | 94.4% | -753.3% | – |
| Operating Cash Flow | $248 | $10,514 | -$17,223 | $15,389 |
| Capital Expenditures | -$3,492 | -$2,918 | -$3,370 | -$6,279 |
| Free Cash Flow | -$3,244 | $7,596 | -$20,593 | $9,110 |